Neuroone Medical Technologies (NMTC) EBIT Growth (1y) (2011 - 2026)
Neuroone Medical Technologies (NMTC) EBIT Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | -17.50% |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 49.06% |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 30.43% |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 43.83% |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 24.81% |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 49.72% |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 13.00% |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 57.74% |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 16.18% |
| 10 | Neuroone Medical Technologies | 19.64 Mn | 17.59 Mn | 1.18 Mn | -28.50% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -28.50% |
| Mar 31, 2026 | 10.55% |
| Dec 31, 2025 | -199.77% |
| Sep 30, 2025 | 51.32% |
| Jun 30, 2025 | 32.47% |
| Mar 31, 2025 | 7.14% |
| Dec 31, 2024 | 150.47% |
| Sep 30, 2024 | 11.00% |
| Jun 30, 2024 | 20.41% |
| Mar 31, 2024 | 17.44% |
| Dec 31, 2023 | -90.01% |
| Sep 30, 2023 | -126.02% |
| Jun 30, 2023 | -27.12% |
| Mar 31, 2023 | -14.25% |
| Dec 31, 2022 | 36.48% |
| Sep 30, 2022 | 47.04% |
| Jun 30, 2022 | 9.01% |
| Mar 31, 2022 | -27.72% |
| Dec 31, 2021 | -31.07% |
| Sep 30, 2021 | -2,151.75% |